71 related articles for article (PubMed ID: 24439672)
21. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
22. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Guo Y
Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
[TBL] [Abstract][Full Text] [Related]
23. Association of proline-directed protein kinase FA with tumorigenesis, invasion, and poor prognosis of human colon carcinoma.
Chung YC; Chang KJ; Yang CC; Lai MT; Hsu CP; Hsueh SF; Peng CC; Fu HH; Chang YF; Yang SD
Cancer; 2002 Nov; 95(9):1840-7. PubMed ID: 12404276
[TBL] [Abstract][Full Text] [Related]
24. Expressions of Src homology 2 domain-containing phosphatase and its clinical significance in laryngeal carcinoma.
Dong LB; Li GQ; Tian ZH; Wang ZM; Xu K
Genet Mol Res; 2013 Oct; 12(4):4207-12. PubMed ID: 24114215
[TBL] [Abstract][Full Text] [Related]
25. KITENIN is associated with tumor progression in human gastric cancer.
Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
[TBL] [Abstract][Full Text] [Related]
26. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
27. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer.
Ladner RD; Lynch FJ; Groshen S; Xiong YP; Sherrod A; Caradonna SJ; Stoehlmacher J; Lenz HJ
Cancer Res; 2000 Jul; 60(13):3493-503. PubMed ID: 10910061
[TBL] [Abstract][Full Text] [Related]
28. Aplasia ras homolog member I is downregulated in gastric cancer and silencing its expression promotes cell growth in vitro.
Tang HL; Hu YQ; Qin XP; Jazag A; Yang H; Yang YX; Yang XN; Liu JJ; Chen JM; Guleng B; Ren JL
J Gastroenterol Hepatol; 2012 Aug; 27(8):1395-404. PubMed ID: 22497484
[TBL] [Abstract][Full Text] [Related]
29. Loss of KAI1 expression in the progression of colorectal cancer.
Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC
Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
31. Decrease of PDSS2 expression, a novel tumor suppressor, in non-small cell lung cancer.
Chen P; Yu J; Knecht J; Chen Q
Cancer Epidemiol; 2013 Apr; 37(2):166-71. PubMed ID: 23312889
[TBL] [Abstract][Full Text] [Related]
32. [Expression of interleukin-9 in colon cancer tissues and its clinical significance].
Wang J; Dong X; Zhu X; Zhao H; Mao D; Zhao X
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jul; 38(8):943-948. PubMed ID: 30187869
[TBL] [Abstract][Full Text] [Related]
33. Shp-2 Is Dispensable for Establishing T Cell Exhaustion and for PD-1 Signaling In Vivo.
Rota G; Niogret C; Dang AT; Barros CR; Fonta NP; Alfei F; Morgado L; Zehn D; Birchmeier W; Vivier E; Guarda G
Cell Rep; 2018 Apr; 23(1):39-49. PubMed ID: 29617671
[TBL] [Abstract][Full Text] [Related]
34. SCC-S2 is overexpressed in colon cancers and regulates cell proliferation.
Miao Z; Zhao T; Wang Z; Xu Y; Song Y; Wu J; Xu H
Tumour Biol; 2012 Dec; 33(6):2099-106. PubMed ID: 22886548
[TBL] [Abstract][Full Text] [Related]
35.
Xu L; Zhou C; Pan R; Tang J; Wang J; Li B; Huang T; Duan S; Xu C
Oncol Lett; 2020 Mar; 19(3):1693-1700. PubMed ID: 32194661
[No Abstract] [Full Text] [Related]
36. [Expression and Significance of PI-PLCε1 in Colon Cancer].
Li XR; Yang K; Huang XL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 48(6):877-879. PubMed ID: 29260524
[TBL] [Abstract][Full Text] [Related]
37. SHP-2 Interacts with CD81 and Regulates the Malignant Evolution of Colorectal Cancer by Inhibiting Epithelial-Mesenchymal Transition.
Yuan H; Zhao J; Yang Y; Wei R; Zhu L; Wang J; Ding M; Wang M; Gu Y
Cancer Manag Res; 2020; 12():13273-13284. PubMed ID: 33380834
[TBL] [Abstract][Full Text] [Related]
38. Expression and clinical significance of tyrosine phosphatase SHP2 in thyroid carcinoma.
Hu ZQ; Ma R; Zhang CM; Li J; Li L; Hu ZT; Gao QI; Li WM
Oncol Lett; 2015 Sep; 10(3):1507-1512. PubMed ID: 26622699
[TBL] [Abstract][Full Text] [Related]
39. SHP-2 deletion in CD4Cre expressing chondrocyte precursors leads to tumor development with wrist tropism.
McNamara JT; Huntington KE; Borys S; Jayasuriya CT; Brossay L
Sci Rep; 2021 Oct; 11(1):20006. PubMed ID: 34625577
[TBL] [Abstract][Full Text] [Related]
40. Label-free classification of colon cancer grading using infrared spectral histopathology.
Kuepper C; Großerueschkamp F; Kallenbach-Thieltges A; Mosig A; Tannapfel A; Gerwert K
Faraday Discuss; 2016 Jun; 187():105-18. PubMed ID: 27064063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
